Rothschild Investment LLC’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.27K Buy
131
+31
+31% +$1.34K ﹤0.01% 2027
2025
Q4
$5.06K Buy
100
+5
+5% +$178 ﹤0.01% 1872
2025
Q3
$2.76K Sell
95
-15
-14% -$347 ﹤0.01% 2022
2025
Q2
$2.59K Buy
110
+65
+144% +$1.46K ﹤0.01% 1883
2025
Q1
$1.08K Sell
45
-10
-18% -$321 ﹤0.01% 2293
2024
Q4
$2.33K Buy
55
+15
+38% +$664 ﹤0.01% 1721
2024
Q3
$1.77K Buy
40
+25
+167% +$949 ﹤0.01% 1797
2024
Q2
$543 Buy
15
+10
+200% +$397 ﹤0.01% 1961
2024
Q1
$216 Buy
+5
New +$178 ﹤0.01% 1718

Other funds holding VERA

Rothschild Investment LLC's VERA Position: Q1 2026 in Review

Rothschild Investment LLC increased its Vera Therapeutics (VERA) stake by 31% in Q1 2026, buying an estimated $1.34K and bringing the position to 131 shares worth $5.27K. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

Rothschild Investment LLC first reported a position in VERA in Q1 2024 and has held it in 9 quarters since. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Rothschild Investment LLC held 131 shares of Vera Therapeutics worth $5.27K as of Q1 2026.
  • Rothschild Investment LLC bought 31 Vera Therapeutics shares in Q1 2026, an estimated $1.34K.
  • Vera Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2027 holding.
  • Rothschild Investment LLC first reported a position in Vera Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.